PRELUDE CAPITAL MANAGEMENT, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1387508 NEW YORK, NY

Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$298,548

-$1,091,990 QoQ

Shares Held

551

-76.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#644

of 870 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $20,247,336 across 16 Drug Manufacturers - Specialty & Generic names. UTHR ranks #11 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	154,970	$5,250,383
2	ETON	Eton Pharmaceuticals, Inc.	137,572	$4,980,106
3	VTRS	Viatris Inc	159,289	$2,529,509
4	CRON	Cronos Group Inc.	810,163	$2,252,253
5	PCRX	Pacira BioSciences, Inc.	50,635	$1,284,609
6	ZTS	Zoetis Inc.	15,258	$1,096,439
7	LQDA	Liquidia Corp	10,758	$857,735
8	HIMS	Hims & Hers Health, Inc.	12,240	$424,360

All Filings in UTHR

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$298,548	551	-76.5%	Shares	Other	2026-08-14
2026-03-31	$1,390,538	2,345	-37.6%	Shares	Other	2026-05-15
2025-12-31	$1,832,060	3,760	+33.6%	Shares	Other	2026-02-17
2025-09-30	$1,179,656	2,814	-56.1%	Shares	Other	2025-11-14
2023-09-30	$1,448,956	6,415	-80.9%	Shares	Other	2023-11-14
2021-06-30	$6,034,455	33,635	+49.7%	Shares	Sole	2021-08-16
2021-03-31	$3,759,393	22,475	+2.8%	Shares	Other	2021-05-17
2020-12-31	$3,318,129	21,860	+2436.0%	Shares	Other	2021-02-16
2020-09-30	$87,062	862	-79.4%	Shares	Other	2020-11-16
2020-06-30	$505,780	4,180	—	Shares	Other	2020-08-14
No filing history on record for this holder in this stock.